organization · Reporting owner

LMFAO Sponsor, LLC

Disclosed activity across 1 company

Tapewire entity: 122739
SEC CIK: 0001842514

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
SeaStar Medical Holding CorpICU · Entity 7863	10% owner	October 28, 2022	November 01, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

SeaStar Medical Holding Corp

Report date October 28, 2022 · Filed November 01, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	2,587,500	Reported balance After 2022-10-28 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2022-10-28 · Exercise / conversion · Acquired 2,587,500 · Balance 2,587,500 F1: All of the reported shares and warrants are held directly by LMFAO Sponsor, LLC ("Sponsor"). LM Funding America, Inc. is the sole manager of Sponsor and owns a majority of the membership interests in Sponsor, and therefore the Board of Directors of LM Funding America, Inc. has sole voting and dispositive control over the shares held by Sponsor. Under the so-called "rule of three", if voting and dispositive decisions regarding an entity's securities are made by three or more individuals, and a voting or dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity's securities. Under this rule, no individual director of LM Funding America, Inc. exercises voting or dispositive control over any of the securities held by Sponsor, even those in which he or she directly holds a pecuniary interest. Accordingly, none of them is deemed to have or share beneficial ownership of such securities.
Class B Common StockSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2022-10-28 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-10-28 · Exercise / conversion · Disposed 2,587,500 · Balance 0 F2: As described in the Issuer's registration statement on Form S-1 (File No. 333-251962) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock automatically converted into shares of Class A common stock at the time of the Issuer's initial business combination on a one-for-one basis, subject to certain adjustments described therein and have no expiration date. F1: All of the reported shares and warrants are held directly by LMFAO Sponsor, LLC ("Sponsor"). LM Funding America, Inc. is the sole manager of Sponsor and owns a majority of the membership interests in Sponsor, and therefore the Board of Directors of LM Funding America, Inc. has sole voting and dispositive control over the shares held by Sponsor. Under the so-called "rule of three", if voting and dispositive decisions regarding an entity's securities are made by three or more individuals, and a voting or dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity's securities. Under this rule, no individual director of LM Funding America, Inc. exercises voting or dispositive control over any of the securities held by Sponsor, even those in which he or she directly holds a pecuniary interest. Accordingly, none of them is deemed to have or share beneficial ownership of such securities.
WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 · Expires 2027-10-28	Direct	5,738,000	Reported balance After 2022-10-28 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-10-28 · Grant · Acquired 5,738,000 · Balance 5,738,000 F4: The Sponsor acquired these warrants for a purchase price of $1.00 per warrant in connection with the initial public offering of the Issuer. The warrants could only become eligible for exercise upon consummation of the Issuer's initial business combination. Since the exercise of the warrants was contingent upon the closing of the business combination, these warrants were not reported at the time of acquisition. The acquisition is being reported now in connection with the consummation of the Issuer's initial business combination. F3: As described in the Issuer's registration statement on Form S-4 (File No. 333-264993) and the third amended and restated certificate of incorporation of the Issuer, which took effect in connection with the closing of the Issuer's business combination with SeaStar Medical, Inc., a Delaware corporation, on October 28, 2022, all Class A common stock of the Issuer was redesignated as common stock, par value $0.0001 per share. F1: All of the reported shares and warrants are held directly by LMFAO Sponsor, LLC ("Sponsor"). LM Funding America, Inc. is the sole manager of Sponsor and owns a majority of the membership interests in Sponsor, and therefore the Board of Directors of LM Funding America, Inc. has sole voting and dispositive control over the shares held by Sponsor. Under the so-called "rule of three", if voting and dispositive decisions regarding an entity's securities are made by three or more individuals, and a voting or dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity's securities. Under this rule, no individual director of LM Funding America, Inc. exercises voting or dispositive control over any of the securities held by Sponsor, even those in which he or she directly holds a pecuniary interest. Accordingly, none of them is deemed to have or share beneficial ownership of such securities.

Filing footnotes · ownership attribution and instrument terms

F1: All of the reported shares and warrants are held directly by LMFAO Sponsor, LLC ("Sponsor"). LM Funding America, Inc. is the sole manager of Sponsor and owns a majority of the membership interests in Sponsor, and therefore the Board of Directors of LM Funding America, Inc. has sole voting and dispositive control over the shares held by Sponsor. Under the so-called "rule of three", if voting and dispositive decisions regarding an entity's securities are made by three or more individuals, and a voting or dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity's securities. Under this rule, no individual director of LM Funding America, Inc. exercises voting or dispositive control over any of the securities held by Sponsor, even those in which he or she directly holds a pecuniary interest. Accordingly, none of them is deemed to have or share beneficial ownership of such securities.

F2: As described in the Issuer's registration statement on Form S-1 (File No. 333-251962) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock automatically converted into shares of Class A common stock at the time of the Issuer's initial business combination on a one-for-one basis, subject to certain adjustments described therein and have no expiration date.

F3: As described in the Issuer's registration statement on Form S-4 (File No. 333-264993) and the third amended and restated certificate of incorporation of the Issuer, which took effect in connection with the closing of the Issuer's business combination with SeaStar Medical, Inc., a Delaware corporation, on October 28, 2022, all Class A common stock of the Issuer was redesignated as common stock, par value $0.0001 per share.

F4: The Sponsor acquired these warrants for a purchase price of $1.00 per warrant in connection with the initial public offering of the Issuer. The warrants could only become eligible for exercise upon consummation of the Issuer's initial business combination. Since the exercise of the warrants was contingent upon the closing of the business combination, these warrants were not reported at the time of acquisition. The acquisition is being reported now in connection with the consummation of the Issuer's initial business combination.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 28, 2022 Filed Nov 1, 2022 14:31 UTC	SeaStar Medical Holding Corp ICU · Entity 7863	GrantWarrant · Derivative	5,738,000	$1.00 Strike: $11.50	$5,738,000.00	Disclosure SEC source: 0001567619-22-018991 · doc1.xml · derivative · entry 3 LMFAO Sponsor, LLC · CIK 0001842514 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,738,000 Underlying: Common Stock · 5,738,000 shares Expires 2027-10-28 F4 · kind: The Sponsor acquired these warrants for a purchase price of $1.00 per warrant in connection with the initial public offering of the Issuer. The warrants could only become eligible for exercise upon consummation of the Issuer's initial business combination. Since the exercise of the warrants was contingent upon the closing of the business combination, these warrants were not reported at the time of acquisition. The acquisition is being reported now in connection with the consummation of the Issuer's initial business combination. F3 · derivative.underlying: As described in the Issuer's registration statement on Form S-4 (File No. 333-264993) and the third amended and restated certificate of incorporation of the Issuer, which took effect in connection with the closing of the Issuer's business combination with SeaStar Medical, Inc., a Delaware corporation, on October 28, 2022, all Class A common stock of the Issuer was redesignated as common stock, par value $0.0001 per share. F1 · ownership.direct: All of the reported shares and warrants are held directly by LMFAO Sponsor, LLC ("Sponsor"). LM Funding America, Inc. is the sole manager of Sponsor and owns a majority of the membership interests in Sponsor, and therefore the Board of Directors of LM Funding America, Inc. has sole voting and dispositive control over the shares held by Sponsor. Under the so-called "rule of three", if voting and dispositive decisions regarding an entity's securities are made by three or more individuals, and a voting or dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity's securities. Under this rule, no individual director of LM Funding America, Inc. exercises voting or dispositive control over any of the securities held by Sponsor, even those in which he or she directly holds a pecuniary interest. Accordingly, none of them is deemed to have or share beneficial ownership of such securities. Read SEC document
October 28, 2022 Filed Nov 1, 2022 14:31 UTC	SeaStar Medical Holding Corp ICU · Entity 7863	Exercise / conversionClass B Common Stock · Derivative	2,587,500	Not disclosed	Not disclosed	Disclosure SEC source: 0001567619-22-018991 · doc1.xml · derivative · entry 2 LMFAO Sponsor, LLC · CIK 0001842514 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,587,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: As described in the Issuer's registration statement on Form S-1 (File No. 333-251962) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock automatically converted into shares of Class A common stock at the time of the Issuer's initial business combination on a one-for-one basis, subject to certain adjustments described therein and have no expiration date. F2 · price: As described in the Issuer's registration statement on Form S-1 (File No. 333-251962) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock automatically converted into shares of Class A common stock at the time of the Issuer's initial business combination on a one-for-one basis, subject to certain adjustments described therein and have no expiration date. F2 · derivative.exercise_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-251962) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock automatically converted into shares of Class A common stock at the time of the Issuer's initial business combination on a one-for-one basis, subject to certain adjustments described therein and have no expiration date. F2 · derivative.expiration_date: As described in the Issuer's registration statement on Form S-1 (File No. 333-251962) under the heading "Description of Securities--Founder Shares", the shares of Class B common stock automatically converted into shares of Class A common stock at the time of the Issuer's initial business combination on a one-for-one basis, subject to certain adjustments described therein and have no expiration date. F1 · ownership.direct: All of the reported shares and warrants are held directly by LMFAO Sponsor, LLC ("Sponsor"). LM Funding America, Inc. is the sole manager of Sponsor and owns a majority of the membership interests in Sponsor, and therefore the Board of Directors of LM Funding America, Inc. has sole voting and dispositive control over the shares held by Sponsor. Under the so-called "rule of three", if voting and dispositive decisions regarding an entity's securities are made by three or more individuals, and a voting or dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity's securities. Under this rule, no individual director of LM Funding America, Inc. exercises voting or dispositive control over any of the securities held by Sponsor, even those in which he or she directly holds a pecuniary interest. Accordingly, none of them is deemed to have or share beneficial ownership of such securities. Read SEC document
October 28, 2022 Filed Nov 1, 2022 14:31 UTC	SeaStar Medical Holding Corp ICU · Entity 7863	Exercise / conversionCommon Stock	2,587,500	$0.00	$0.00	Disclosure SEC source: 0001567619-22-018991 · doc1.xml · nonDerivative · entry 1 LMFAO Sponsor, LLC · CIK 0001842514 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,587,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.direct: All of the reported shares and warrants are held directly by LMFAO Sponsor, LLC ("Sponsor"). LM Funding America, Inc. is the sole manager of Sponsor and owns a majority of the membership interests in Sponsor, and therefore the Board of Directors of LM Funding America, Inc. has sole voting and dispositive control over the shares held by Sponsor. Under the so-called "rule of three", if voting and dispositive decisions regarding an entity's securities are made by three or more individuals, and a voting or dispositive decision requires the approval of a majority of those individuals, then none of the individuals is deemed a beneficial owner of the entity's securities. Under this rule, no individual director of LM Funding America, Inc. exercises voting or dispositive control over any of the securities held by Sponsor, even those in which he or she directly holds a pecuniary interest. Accordingly, none of them is deemed to have or share beneficial ownership of such securities. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.